As of 2025-07-06, the Intrinsic Value of RPG Life Sciences Ltd (RPGLIFE.NS) is 1,362.39 INR. This RPGLIFE.NS valuation is based on the model Discounted Cash Flows (Growth Exit 5Y). With the current market price of 2,521.00 INR, the upside of RPG Life Sciences Ltd is -46.00%.
The range of the Intrinsic Value is 1,122.82 - 1,783.28 INR
Based on its market price of 2,521.00 INR and our intrinsic valuation, RPG Life Sciences Ltd (RPGLIFE.NS) is overvalued by 46.00%.
| Range | Selected | Upside | |
| a | |||
| DCF (Growth 5y) | 1,122.82 - 1,783.28 | 1,362.39 | -46.0% |
| DCF (Growth 10y) | 1,270.04 - 1,947.49 | 1,519.03 | -39.7% |
| DCF (EBITDA 5y) | 1,507.37 - 1,896.04 | 1,598.67 | -36.6% |
| DCF (EBITDA 10y) | 1,546.07 - 2,040.60 | 1,700.55 | -32.5% |
| Fair Value | 2,769.65 - 2,769.65 | 2,769.65 | 9.86% |
| P/E | 1,613.42 - 2,525.92 | 2,019.15 | -19.9% |
| EV/EBITDA | 1,003.36 - 1,403.99 | 1,187.12 | -52.9% |
| EPV | 596.10 - 736.17 | 666.14 | -73.6% |
| DDM - Stable | 385.26 - 827.31 | 606.29 | -76.0% |
| DDM - Multi | 380.46 - 662.28 | 485.48 | -80.7% |
| Market Cap (mil) | 41,697.34 |
| Beta | 1.04 |
| Outstanding shares (mil) | 16.54 |
| Enterprise Value (mil) | 40,301.24 |
| Market risk premium | 8.31% |
| Cost of Equity | 19.59% |
| Cost of Debt | 7.46% |
| WACC | 12.57% |